Accordingly, in a retrospective study that we conducted, we found that patients with PMF and secondary MF harboring the SF3B1 mutation had anemia and a high transfusion burden [59], in line with the impaired erythroid differentiation and anemia noted in SF3B1-mutated patients with MDS. Here, SF3B1 is linked to anemia (phenotype).